FTH logo

Faeth Therapeutics, Inc.

FTH
Healthcare|Biotechnology|US
$22.05
+2.13 (+10.69%)
DCF Value
$5.16
Tangible Book / Share
$6.50
Cash / Share
$6.76
Next Earnings Report
Mar 29, 2027
EPS est. -$0.70
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Jun 18, 2026 (S-3ASR). Possible dilution.

Upcoming Data Readouts (2)

Sep 2028
Est. completion
P2Endometrial Cancer
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
NCT06463028n=40
May 2029
Est. completion
P1P2HR+ HER2- Breast Cancer
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
NCT07558733n=32

Recent Press Releases

Faeth to Report PIK-201 Phase 2 Data and Host Virtual Event on November 9, 2026
Nov 6, 2026 · Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 5, 2026 · Business Wire
Faeth Therapeutics Reports Third Quarter 2026 Financial Results and Operational Updates
Nov 3, 2026 · Business Wire
Faeth Appoints Adam Schayowitz, Ph.D., MBA, Head of Research and Development at Zymeworks, to Board of Directors
Oct 27, 2026 · Business Wire
Faeth Presents Updated Preclinical Data at ESMO, including First-Ever Head-to-Head Characterization of PIKTOR against Gedatolisib
Oct 23, 2026 · Business Wire
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 22, 2026 · Business Wire
Faeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026
Oct 19, 2026 · Business Wire
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
Sep 17, 2026 · Business Wire
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
Sep 8, 2026 · Business Wire
Faeth Therapeutics to Participate in Upcoming September Investor Conferences
Sep 1, 2026 · Business Wire

SEC Filings (68)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 3, 2026S-8Employee stock planDocumentIndex
Nov 3, 20268-KMaterial eventDocumentIndex
Nov 3, 202610-QQuarterly reportDocumentIndex
Oct 27, 20268-KMaterial eventDocumentIndex
Sep 17, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 4, 202610-QQuarterly reportDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 23, 20268-KMaterial eventDocumentIndex
Jun 23, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 23, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 18, 20268-KMaterial eventDocumentIndex
Jun 18, 2026S-3ASRShelf registrationDocumentIndex
Jun 15, 20268-KMaterial eventDocumentIndex
Jun 12, 2026EFFECTDocumentIndex
Jun 10, 2026S-3/AShelf registrationDocumentIndex
Jun 10, 20268-KMaterial eventDocumentIndex
Jun 2, 202610-K/AAnnual reportDocumentIndex
Jun 2, 2026S-3/AShelf registrationDocumentIndex
May 22, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 21, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2026S-8Employee stock planDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
Apr 28, 2026S-3Shelf registrationDocumentIndex
Apr 27, 2026ARSAnnual report to holdersDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 27, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Apr 16, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 15, 20268-K/AMaterial eventDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex